Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|December 10, 2009
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisTom Jefferson, Mark Jones, Peter Doshi, et al.
JAMA Internal Medicine|March 5, 2019
Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017Peter Doshi, O'Mareen Spence, Aida Kuzucan, et al.
Journal of General Internal Medicine|October 30, 2019
Reporting of Drug Benefit in FDA-Approved Prescription Drug LabelingBansri Desai, Kyungwan Hong, John H Powers, et al.
Journal of General Internal Medicine|February 9, 2022
Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved MedicationsKyungwan Hong, Sarah Tanveer, Hazem E Hassan, et al.
Trials|May 5, 2018
Patient consent to publication and data sharing in industry and NIH-funded clinical trialsO'Mareen Spence, Richie Onwuchekwa Uba, Seongbin Shin, et al.
Lancet (London, England)|October 20, 2009
Possible harms of oseltamivir--a call for urgent actionTom Jefferson, Mark Jones, Peter Doshi, et al.
BMJ (Clinical Research Ed.)|December 24, 2021
Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phaseChristof Prugger, Angela Spelsberg, Ulrich Keil, et al.
BMJ (Clinical Research Ed.)|November 17, 2015
Visualising childhood vaccination schedules across G8 countriesPeter Doshi, Will Stahl-Timmins, José G Merino, et al.
BMJ (Clinical Research Ed.)|June 15, 2013
Restoring invisible and abandoned trials: a call for people to publish the findingsPeter Doshi, Kay Dickersin, David Healy, et al.
Lancet (London, England)|March 21, 2021
Control vaccine formulationPeter Doshi, Kyungwan Hong, Tom Jefferson, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|December 10, 2009
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisTom Jefferson, Mark Jones, Peter Doshi, et al.
JAMA Internal Medicine|March 5, 2019
Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017Peter Doshi, O'Mareen Spence, Aida Kuzucan, et al.
Journal of General Internal Medicine|October 30, 2019
Reporting of Drug Benefit in FDA-Approved Prescription Drug LabelingBansri Desai, Kyungwan Hong, John H Powers, et al.
Journal of General Internal Medicine|February 9, 2022
Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved MedicationsKyungwan Hong, Sarah Tanveer, Hazem E Hassan, et al.
Trials|May 5, 2018
Patient consent to publication and data sharing in industry and NIH-funded clinical trialsO'Mareen Spence, Richie Onwuchekwa Uba, Seongbin Shin, et al.
Lancet (London, England)|October 20, 2009
Possible harms of oseltamivir--a call for urgent actionTom Jefferson, Mark Jones, Peter Doshi, et al.
BMJ (Clinical Research Ed.)|December 24, 2021
Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phaseChristof Prugger, Angela Spelsberg, Ulrich Keil, et al.
BMJ (Clinical Research Ed.)|November 17, 2015
Visualising childhood vaccination schedules across G8 countriesPeter Doshi, Will Stahl-Timmins, José G Merino, et al.
BMJ (Clinical Research Ed.)|June 15, 2013
Restoring invisible and abandoned trials: a call for people to publish the findingsPeter Doshi, Kay Dickersin, David Healy, et al.
Lancet (London, England)|March 21, 2021
Control vaccine formulationPeter Doshi, Kyungwan Hong, Tom Jefferson, et al.
Pageof 15